New CRISPR-Cas Enzymes Discovered

A metagenomics analysis finds Cas9 in archaea for the first time, along with two previously unknown Cas nucleases from bacteria.

kerry grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIPEDIA, THOMAS SPLETTSSTOESSERMicrobes use a number of CRISPR-Cas systems for immunity, but it’s the class 2 system, typically utilizing the nuclease Cas9, that has been adapted for genome editing. A metagenomics search of microbes sampled from soil, groundwater, an acid mine drainage site in Colorado, and a Utah geyser has led to the discovery of additional class 2 CRISPR-Cas programs, including the first Cas9 identified in archaea and two small Cas enzymes in bacteria. Researchers published their findings in Nature today (December 22).

“It’s really cool to unearth gold out of the metagenomic dark matter,” said Rodolphe Barrangou, who studies CRISPR at North Carolina State University and was not involved in the study. “There’s so much more in nature than people appreciate.”

Although CRISPR is perhaps best known as a laboratory tool for tinkering with genetic sequences and functions, its origins lie in defending microbes from invaders. Scientists developed CRISPR as a genomic editor from bacteria grown in the lab, but countless microbes remain uncultivated—that is, not isolated and grown in culture. Therefore, the potential for discovering new forms of CRISPR is vast.

Over the past decade, Jillian Banfield of the University of California, Berkeley, and colleagues have been collecting microbes from various locations, extracting their DNA, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo